Sun Pharma acquires Organon in $11.75 billion deal

Indian pharmaceutical company Sun Pharma announces acquisition of U.S. drugmaker Organon for $11.75 billion in cash.

Published 17sem1 sourceMajorupdated 2sem

≈ 17sSpeed

The fact

The deal strengthens Sun Pharma's footprint in the global pharmaceutical market.

Sun Pharma shares surge following the announcement.

Click the link to read an article on the topic:

Explore this topic

Consolidation du secteur pharmaceutique

Renforcement de la position indienne en santé mondiale

Auto-synthesis from 1 media source · identified on April 27, 2026